Close Menu

Quicker, Sure…

DrugMonkey goes into a bit more detail about the new NIH grant application policy that limits applicants to one amendment (currently applications are limited to two amendments, as established in 1996). The blogger wades through some data and is still at a loss to understand how a new limit will "ensure earlier funding of high-quality applications and improve efficiencies in the peer review system" as the NIH press release says. "So I'm still at a loss.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.